2boa

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 4: Line 4:
==Overview==
==Overview==
-
Treatment of advanced stages of prostate carcinoma with, histone-deacetylase inhibitors entails expression of human, procarboxypeptidase-A4 (hPCPA4). The three-dimensional structure of hPCPA4, has been solved and shows the features of related metallocarboxypeptidase, zymogens, with a preformed alpha/beta/-hydrolase active-enzyme moiety, (hCPA4) and an inhibiting pro-domain (PD). The protease moiety recalls a, sphere, out of which a spherical cone has been cut. This results in a, funnel-like structure, at the bottom of which the active-site cleft, resides. The border of this funnel is shaped by loops, which are, responsible for the interaction with the PD, characterised by a large, interface area and relatively few contacts. Such an inhibitory mode is, evocative of the recently reported structure of the human inhibitor, latexin in its complex with hCPA4. The main contacting structure of, latexin is similar to the one employed for PD inhibition. In both cases, active-site blocking relies mainly on a loop provided by the central part, of a beta sheet.
+
Treatment of advanced stages of prostate carcinoma with histone-deacetylase inhibitors entails expression of human procarboxypeptidase-A4 (hPCPA4). The three-dimensional structure of hPCPA4 has been solved and shows the features of related metallocarboxypeptidase zymogens, with a preformed alpha/beta/-hydrolase active-enzyme moiety (hCPA4) and an inhibiting pro-domain (PD). The protease moiety recalls a sphere, out of which a spherical cone has been cut. This results in a funnel-like structure, at the bottom of which the active-site cleft resides. The border of this funnel is shaped by loops, which are responsible for the interaction with the PD, characterised by a large interface area and relatively few contacts. Such an inhibitory mode is evocative of the recently reported structure of the human inhibitor latexin in its complex with hCPA4. The main contacting structure of latexin is similar to the one employed for PD inhibition. In both cases, active-site blocking relies mainly on a loop provided by the central part of a beta sheet.
==About this Structure==
==About this Structure==
Line 13: Line 13:
[[Category: Homo sapiens]]
[[Category: Homo sapiens]]
[[Category: Single protein]]
[[Category: Single protein]]
-
[[Category: Aviles, F.X.]]
+
[[Category: Aviles, F X.]]
[[Category: Bonet-Figueredo, R.]]
[[Category: Bonet-Figueredo, R.]]
[[Category: Garcia-Castellanos, R.]]
[[Category: Garcia-Castellanos, R.]]
-
[[Category: Gomis-Ruth, F.X.]]
+
[[Category: Gomis-Ruth, F X.]]
[[Category: Pallares, I.]]
[[Category: Pallares, I.]]
[[Category: Vendrell, J.]]
[[Category: Vendrell, J.]]
Line 31: Line 31:
[[Category: zymogen]]
[[Category: zymogen]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Feb 3 10:26:17 2008''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 16:39:52 2008''

Revision as of 14:39, 21 February 2008


2boa, resolution 2.2Å

Drag the structure with the mouse to rotate

HUMAN PROCARBOXYPEPTIDASE A4.

Overview

Treatment of advanced stages of prostate carcinoma with histone-deacetylase inhibitors entails expression of human procarboxypeptidase-A4 (hPCPA4). The three-dimensional structure of hPCPA4 has been solved and shows the features of related metallocarboxypeptidase zymogens, with a preformed alpha/beta/-hydrolase active-enzyme moiety (hCPA4) and an inhibiting pro-domain (PD). The protease moiety recalls a sphere, out of which a spherical cone has been cut. This results in a funnel-like structure, at the bottom of which the active-site cleft resides. The border of this funnel is shaped by loops, which are responsible for the interaction with the PD, characterised by a large interface area and relatively few contacts. Such an inhibitory mode is evocative of the recently reported structure of the human inhibitor latexin in its complex with hCPA4. The main contacting structure of latexin is similar to the one employed for PD inhibition. In both cases, active-site blocking relies mainly on a loop provided by the central part of a beta sheet.

About this Structure

2BOA is a Single protein structure of sequence from Homo sapiens with , and as ligands. Known structural/functional Site: . Full crystallographic information is available from OCA.

Reference

Detailed molecular comparison between the inhibition mode of A/B-type carboxypeptidases in the zymogen state and by the endogenous inhibitor latexin., Garcia-Castellanos R, Bonet-Figueredo R, Pallares I, Ventura S, Aviles FX, Vendrell J, Gomis-Rutha FX, Cell Mol Life Sci. 2005 Sep;62(17):1996-2014. PMID:16091843

Page seeded by OCA on Thu Feb 21 16:39:52 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools